Loading clinical trials...

Magnetic Resonance Elastography of Cardiac Transplant Rejection | Clinical Trials | Clareo Health

TERMINATEDNA

Magnetic Resonance Elastography of Cardiac Transplant Rejection

NCT02266914•Ohio State University

View on ClinicalTrials.gov

Summary

Magnetic Resonance Elastography (MRE) for cardiac transplant patients.

Detailed Description

Patient will undergo MRE beginning 4-8 weeks post transplant, then with each scheduled cardiac biopsy through 7-8 months post transplant. Results of the MRE will be compared against results of the cardiac biopsy to determine if the non-invasive MRE can predict cardiac transplant rejection.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients must have undergone cardiac transplantation at the Ohio State University Ross Heart Hospital.
•Patients must be able to lie flat on their back in the scanner for up to 60 minutes
•Patient must be able to hold their breath for up to 15 seconds at a time.

Exclusion Criteria

•Patients who are claustrophobic
•Patients who are pregnant, due to potential risks to the fetus.
•Patients with any unapproved, non-MRI safe metal/devices in their bodies.

Locations (1)

The Ohio State University Medical Center

Columbus, Ohio, United States

Key Dates

Start Date

January 27, 2014

Primary Completion Date

December 1, 2017

Completion Date

December 1, 2017

Last Updated

May 22, 2019

Enrollment

ACTUAL participants

Conditions

Acute Graft Rejection

Interventions

Magnetic Resonance Elastography driver

DEVICE

Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR

NCT02581436

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 22, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions